Underdetection, Not Overdiagnosis, Is The Real Problem in Breast Cancer Screening
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
A new review article discusses the topics of overdiagnosis and overtreatment and the role of providers and technology to address the issues in the context of population health. The article appears in the journal Population Health Management.
The article provides a detailed review of the benefits and limitations of current screening mammography practices, and outlines the complexities of the issues from both clinical and methodological perspectives. Coauthors Elizabeth Morris, MD, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College (New York, NY), Stephen Feig, MD, University of California Irvine Medical Center and School of Medicine, Madeline Drexler, Harvard T.H. Chan School of Public Health (Boston, MA), and Constance Lehman, MD, Massachusetts General Hospital (Boston, MA) state that "the key goal should not be less diagnosis but better information and improved treatment decision tools."